Japan Lifeline Co., Ltd.

TSE:7575 Stock Report

Market Cap: JP¥89.3b

Japan Lifeline Valuation

Is 7575 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 7575 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 7575 (¥1274) is trading below our estimate of fair value (¥2452.58)

Significantly Below Fair Value: 7575 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 7575?

Key metric: As 7575 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 7575. This is calculated by dividing 7575's market cap by their current earnings.
What is 7575's PE Ratio?
PE Ratio11.3x
EarningsJP¥7.92b
Market CapJP¥89.31b

Price to Earnings Ratio vs Peers

How does 7575's PE Ratio compare to its peers?

The above table shows the PE ratio for 7575 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average16.8x
7817 Paramount Bed Holdings
19.3x15.4%JP¥146.2b
7749 MedikitLtd
13.3xn/aJP¥40.4b
6960 Fukuda Denshi
12.7x5.6%JP¥211.0b
7716 Nakanishi
21.8x10.4%JP¥189.3b
7575 Japan Lifeline
11.3x6.8%JP¥89.3b

Price-To-Earnings vs Peers: 7575 is good value based on its Price-To-Earnings Ratio (11.3x) compared to the peer average (16.8x).

Price to Earnings Ratio vs Industry

How does 7575's PE Ratio compare vs other companies in the JP Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
7575 11.3xIndustry Avg. 15.7xNo. of Companies6PE01224364860+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 7575 is good value based on its Price-To-Earnings Ratio (11.3x) compared to the JP Medical Equipment industry average (14.3x).

Price to Earnings Ratio vs Fair Ratio

What is 7575's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

7575 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio11.3x
Fair PE Ratio16.7x

Price-To-Earnings vs Fair Ratio: 7575 is good value based on its Price-To-Earnings Ratio (11.3x) compared to the estimated Fair Price-To-Earnings Ratio (16.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 7575 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentJP¥1,274.00
JP¥1,388.25
+9.0%
5.8%JP¥1,500.00JP¥1,300.00n/a4
Nov ’25JP¥1,260.00
JP¥1,388.25
+10.2%
5.8%JP¥1,500.00JP¥1,300.00n/a4
Oct ’25JP¥1,241.00
JP¥1,365.75
+10.1%
5.8%JP¥1,500.00JP¥1,300.00n/a4
Sep ’25JP¥1,123.00
JP¥1,365.75
+21.6%
5.8%JP¥1,500.00JP¥1,300.00n/a4
Aug ’25JP¥1,124.00
JP¥1,315.75
+17.1%
1.2%JP¥1,338.00JP¥1,300.00n/a4
Jul ’25JP¥1,147.00
JP¥1,368.75
+19.3%
7.7%JP¥1,550.00JP¥1,300.00n/a4
Jun ’25JP¥1,139.00
JP¥1,391.67
+22.2%
8.1%JP¥1,550.00JP¥1,300.00n/a3
May ’25JP¥1,160.00
JP¥1,333.33
+14.9%
12.4%JP¥1,550.00JP¥1,150.00n/a3
Apr ’25JP¥1,199.00
JP¥1,450.00
+20.9%
17.1%JP¥1,800.00JP¥1,150.00n/a4
Mar ’25JP¥1,299.00
JP¥1,450.00
+11.6%
17.1%JP¥1,800.00JP¥1,150.00n/a4
Feb ’25JP¥1,333.00
JP¥1,257.50
-5.7%
12.3%JP¥1,500.00JP¥1,100.00n/a4
Jan ’25JP¥1,263.00
JP¥1,257.50
-0.4%
12.3%JP¥1,500.00JP¥1,100.00n/a4
Dec ’24JP¥1,172.00
JP¥1,190.00
+1.5%
7.6%JP¥1,280.00JP¥1,100.00n/a2
Aug ’24JP¥990.00
JP¥1,095.00
+10.6%
0.5%JP¥1,100.00JP¥1,090.00JP¥1,124.002
Jul ’24JP¥1,030.00
JP¥1,096.67
+6.5%
0.4%JP¥1,100.00JP¥1,090.00JP¥1,147.003
Jun ’24JP¥1,024.00
JP¥1,072.50
+4.7%
3.9%JP¥1,100.00JP¥1,000.00JP¥1,139.004
May ’24JP¥944.00
JP¥1,035.00
+9.6%
6.1%JP¥1,100.00JP¥950.00JP¥1,160.004
Apr ’24JP¥916.00
JP¥1,035.00
+13.0%
6.1%JP¥1,100.00JP¥950.00JP¥1,199.004
Mar ’24JP¥947.00
JP¥1,035.00
+9.3%
6.1%JP¥1,100.00JP¥950.00JP¥1,299.004
Feb ’24JP¥941.00
JP¥1,035.00
+10.0%
6.1%JP¥1,100.00JP¥950.00JP¥1,333.004
Jan ’24JP¥916.00
JP¥1,050.00
+14.6%
6.7%JP¥1,150.00JP¥1,000.00JP¥1,263.003
Dec ’23JP¥948.00
JP¥1,032.50
+8.9%
6.6%JP¥1,150.00JP¥980.00JP¥1,172.004
Nov ’23JP¥980.00
JP¥1,050.00
+7.1%
6.4%JP¥1,150.00JP¥980.00JP¥1,151.004

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

FINDEX

JP¥20.8b

Offers medical systems, office systems, and Healthtech products in Japan.

3649

JP¥812.00

7D

-0.5%

1Y

-12.3%

TOKAI

JP¥75.1b

Provides various healthy life services in Japan.

9729

JP¥2,221.00

7D

1.4%

1Y

17.5%

Charm Care

JP¥39.5b

Engages in nursing care business.

6062

JP¥1,210.00

7D

0.08%

1Y

2.3%